PECAM1 and neoplasm: The combination of the two drugs had considerable effects on the tumor stroma, significantly inhibiting fibrosis (Sirius red staining) and angiogenesis (CD31) (Supplementary Fig. 5) and inducing a non statistically significant increase in tumor cell death (cleaved Caspase3).